Showing results (1-10 of 324) with videos related to

Sort By:
Pageof 33
Handbook of Experimental Pharmacology|April 14, 2006
Hsp90 inhibitors in the clinicS Pacey, U Banerji, I Judson, et al.
Oncogene|August 30, 2000
Gene expression profiling of human colon cancer cells following inhibition of signal transduction by 17-allylamino-17-demethoxygeldanamycin, an inhibitor of the hsp90 molecular chaperoneP A Clarke, I Hostein, U Banerji, et al.
Clinical Pharmacology and Therapeutics|January 20, 2009
From darkness to light with biomarkers in early clinical trials of cancer drugsC P Carden, U Banerji, S B Kaye, et al.
British Journal of Cancer|April 30, 2009
Clinical benefit in Phase-I trials of novel molecularly targeted agents: does dose matter?S Postel-Vinay, H-T Arkenau, D Olmos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 15, 2010
Targeted therapies in soft tissue sarcomasI Judson
International Journal of Radiation Oncology, Biology, Physics|April 1, 1989
Accelerated elimination of pimonidazole following microsomal enzyme induction in mice: a possible approach to reduced neurotoxicity of the pimonidazole-etanidazole combinationP Workman
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1990
The cell membrane and cell signals: new targets for novel anticancer drugsP Workman
Oncology Research|January 1, 1994
Enzyme-directed bioreductive drug development revisited: a commentary on recent progress and future prospects with emphasis on quinone anticancer agents and quinone metabolizing enzymes, particularly DT-diaphoraseP Workman
Cancer Clinical Trials|January 1, 1980
Pharmacokinetics of hypoxic cell radiosensitizers: a reviewP Workman
Current Cancer Drug Targets|August 22, 2002
New drug targets for genomic cancer therapy: successes, limitations, opportunities and future challengesP Workman
Pageof 33